The Pfizer Incubator

Pfizer La Jolla 10777 Science Center Drive

San Diego, CA 92121

858- 530-8190

Abstract Description

Management

Keywords

Comment | Printable Version | 1 of 1 | |

network/, Consulting and Advisory/, Incubator

Description

The Pfizer Incubator (TPI) offers scientist-entrepreneurs an opportunity to bring their medical innovations to patients. In TPI, scientist-entrepreneurs contribute innovative ideas and the ability to solve complex scientific and technical challenges, while TPI provides all necessary resources to move ideas forward into practice. If the idea is proven and is ready to be commercialized, it can be incorporated into one of the most powerful life science research, development and marketing infrastructures in the world.

Program/Products/Services

The Pfizer Incubator will invest in innovative research plans and brilliant people. Although individual circumstances will certainly be different, we anticipate committing funding for 24 months of operation based on milestones spaced roughly six months apart. We recognize that research is rarely linear or predictable, and we will help facilitate the adjustment of business plans as progress is made to ensure that most relevant milestones are set. The Pfizer Incubator's first laboratories are on the Pfizer campus in La Jolla, California. They reside in a modern building built in 2004 and consist of 5 separate dedicated labs (expandable to 8) and 23 offices in 28,000 square feet of flexible space. The labs can be configured for doing either chemistry or biology. Most of the commonly used laboratory equipment is available along with scientific and facility services. Incubated companies will conduct business under TPI's regulatory licenses and permits. The Pfizer Incubator will provide incubated companies and projects with basic facility and scientific services to support scientific innovation, such as IT support services, glass wash facilities, hazardous waste pickup and disposal, equipment calibration, lab and office housekeeping, security presence, shipping and receiving. Incubated companies will be responsible for operating expenses not included in TPI service package, including lab supplies, bookkeeping and payroll services, liability and workers' compensation insurance, as well as legal counsel.

Customers/Clients

Fabrus LLC is the first company to enter The Pfizer Incubator and was founded by Vaughn Smider, PhD, an assistant professor at The Scripps Research Institute. Fabrus LLC is developing a novel technology platform to enable the identification of unique therapeutic antibodies that might lead to new therapies. The technology will allow screening for antibodies with functional activity and the company will be developing novel antibody libraries and ways to screen them against biological targets. Wintherix LLC was founded by a team led by Dr. Dennis Carson, Director of the Moores Cancer Center and Professor of Medicine at UCSD School of Medicine. The new company will use its proprietary biological knowledge and Pfizer's compound library to search for molecules that inhibit wnt-related signaling pathways in cancer cells. Wnt-signaling is thought to play a role in the development of cancer in humans and represents a potential new way to treat the disease. RGo Bioscience LLC was co-founded by Dr. Alexander Chucholowski, previously President of ChemBridge Research Laboratories (CRL), and Dr. Thomas Hermann, an Assistant Professor at the University of California, San Diego (UCSD), where he researches the potential of small molecules to act on ribonucleic acid (RNA). RNA plays a key role in many disease mechanisms and the new company aims to develop novel ways to deliver RNAs into the human body.

2012-02-08-926 SELECT * FROM `master` WHERE CompanyID='11105' AND `Profile_Type` LIKE 'resource' AND `Approved` LIKE 'YES' ORDER BY `Member_Priority` ASC LIMIT 0 , 30